Respiratory Disorder Clinical Trial
— TeleCáceresOfficial title:
Clinical Validation of Tele-stethoscope System Digital Bluetooth Ehas-fundatel
Verified date | July 2022 |
Source | Sociedad Española de Neumología y Cirugía Torácica |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Acute respiratory infections and other respiratory and cardiology diseases like COPD or heart failure are important causes of morbidity and mortality around the world. Telemedicine is defined as the delivery of health care and the sharing of medical knoledge over distances using telecommunication systems. Inexpensive techologies offer the possibility of a direct, real-time connection between the patient or the other end. These technologies help to the physicians to manage different symptoms and cardio-respiratory diseases. A real-time wireless tele-stethoscopy system was designed to allow a physician to receive real-time cardio-respiratory sounds from a remote auscultation, as well as video images showing where the technician is placing the stethoscope on the patient´s body. Actually, the lack of physicians in rural areas of developing countries makes difficult their correct diagnosis and treatment. Furthermore, in the majority of health systems, the patients are shared between primary care and medical specialty in hospitals. The tele-stethoscopy system through telemedicine could help to the physicians or health-care technicians in the majority of health systems and especially in rural areas of developing countries without physicians to manage the patients. For this reason, the goal of this project is the clinical validation of an open real-time tele-stethoscope systme (EHAS-Fundatel digital stethoscope) previously designed, with different specialist (pneumologists, cardiologists and internists.)
Status | Completed |
Enrollment | 40 |
Est. completion date | December 27, 2018 |
Est. primary completion date | November 27, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Informed consent sign. - Pacient admitted to hospital with any disease but no inestable disease. Exclusion Criteria: - The lack of informed consent. - Inestable disease. |
Country | Name | City | State |
---|---|---|---|
Spain | San Pedro de Alcántara Hospital | Cáceres |
Lead Sponsor | Collaborator |
---|---|
Sociedad Española de Neumología y Cirugía Torácica |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intra-observer agreement for heart murmurs auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will randomize the first auscultation (baseline auscultation) into tele-stethoscope system or conventional stethoscope. After 1 hour, we will use the other auscultation method.
The investigators will measure if there is a heart murmur or not and the intra-observer agreement by the kappa index in the heart murmurs auscultation. |
change from baseline auscultation to final auscultation (after 1 hour) | |
Primary | Intra-observer agreement for heart rhythm auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a heart rhythm auscultation or not rhythm and the intra-observer agreement by the kappa index in the heart rhythm auscultation. | change from baseline auscultation to final auscultation (after 1 hour) | |
Primary | Intra-observer agreement for vesicular murmur auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a normal vesicular murmur or not and the intra-observer agreement by the kappa index in the vesicular murmur auscultation. | change from baseline auscultation to final auscultation (after 1 hour) | |
Primary | Intra-observer agreement for lung rales sounds using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a lung rale sound or not and the intra-observer agreement by the kappa index in the lung rale sound. | change from baseline auscultation to final auscultation (after 1 hour) | |
Secondary | Inter-observer agreement for for heart murmurs auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will randomize the first auscultation (baseline auscultation) into tele-stethoscope system or conventional stethoscope. After 1 hour, we will use the other auscultation method.
The investigators will measure if there is a heart murmur or not and the inter-observer agreement by the kappa index in the heart murmurs auscultation. |
change from baseline auscultation to final auscultation (after 1 hour) | |
Secondary | Inter-observer agreement for heart rhythm auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a heart rhythm auscultation or not rhythm and the inter-observer agreement by the kappa index in the heart rhythm auscultation. | change from baseline auscultation to final auscultation (after 1 hour) | |
Secondary | Inter-observer agreement for vesicular murmur auscultation using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a normal vesicular murmur or not and the inter-observer agreement by the kappa index in the vesicular murmur auscultation. | change from baseline auscultation to final auscultation (after 1 hour) | |
Secondary | Inter-observer agreement for lung rales sounds using the two methods (tele-stethoscope and conventional stethoscope) | The investigators will measure if there is a lung rale sound or not and the inter-observer agreement by the kappa index in the lung rale sound. | change from baseline auscultation to final auscultation (after 1 hour) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05973201 -
Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy
|
N/A | |
Not yet recruiting |
NCT06237322 -
Study of RE.DOCTOR Vitals® Software Accuracy
|
||
Completed |
NCT04763746 -
The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development
|
||
Completed |
NCT04678856 -
Dupilumab in CRSsNP
|
Phase 2 |